WallStreetZenWallStreetZen

NASDAQ: INZY
Inozyme Pharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Inozyme Pharma earnings were -$102.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest INZY earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$27.1M, up 10.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INZY reported annual earnings of -$102.0M, with 43.4% growth. The next INZY earnings date is May 5, 2025.

INZY earnings history

Current Revenue
$0.0
Current Earnings
-$102.0M
Current Profit Margin
0%

INZY Return on Equity

Current Company
-115.3%
Current Industry
-2%
Current Market
34.1%
INZY's Return on Equity (-115.3%)... subscribe to Premium to read more.
High Return on Equity Performance

INZY undefined

Current Company
-68.1%
Current Industry
-0.4%
INZY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INZY announces earnings.

INZY undefined

Current Company
-108.04%
Current Industry
5.9%
INZY's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INZY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INZY-$95.16M-$102.02MN/A-$1.62
ANRO-$59.22M-$61.43MN/A-$2.50
ANL-$49.89M-$54.07MN/A$0.93
VTVT-$18.27M-$18.46MN/A-$3.20
RANI-$22.15M-$30.02MN/A-$1.05
View Top Biotech Stocks

INZY earnings dates

Next earnings date
May 5, 2025

Inozyme Pharma Earnings Reports & History FAQ

What were Inozyme Pharma's earnings last quarter?

On INZY's earnings call on Invalid Date, Inozyme Pharma (NASDAQ: INZY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 20% year over year. Total INZY earnings for the quarter were -$27.07 million. In the same quarter last year, Inozyme Pharma's earnings per share (EPS) was -$0.35.

If you're new to stock investing, here's how to buy Inozyme Pharma stock.

When does Inozyme Pharma report earnings?

The next INZY earnings call is Invalid Date. Add INZY to your watchlist to be reminded of Inozyme Pharma's next earnings date.

Is Inozyme Pharma profitable or losing money?

As of the last Inozyme Pharma earnings report, Inozyme Pharma is currently losing money. Inozyme Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$102.02 million, a 43.35% increase year over year.

What was INZY's earnings growth in the past year?

As of Inozyme Pharma's earnings date in Invalid Date, Inozyme Pharma's earnings has grown year over year. INZY earnings in the past year totalled -$102.02 million.

What are Inozyme Pharma's earnings expectations?

The current EPS estimate for Inozyme Pharma's earnings report in Invalid Date is -$0.36.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.